The combined systemic and topical administration of voriconazole has successfully been used to treat keratomycosis. Because no voriconazole eye drop product is commercially available, we prepared a sterile eye drop solution (10 mg/ml). Voriconazole remains stable over 30 days, providing an eye drop solution suitable for use for the topical treatment of fungal keratitis. Copyright © 2009, American Society for Microbiology. All Rights Reserved.
CITATION STYLE
Dupuis, A., Tournier, N., Le Moal, G., & Venisse, N. (2009). Preparation and stability of voriconazole eye drop solution. Antimicrobial Agents and Chemotherapy, 53(2), 798–799. https://doi.org/10.1128/AAC.01126-08
Mendeley helps you to discover research relevant for your work.